Insider buying last 90 days
No open-market insider purchases were filed for FMS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every FMS insider filing, plotted on the chart in Gekko.Open FMS in Gekko
Fresenius Medical Care (FMS) Stock Analysis & Forecast
Sep 28 close
$22.95+0.26 (+1.1%)
Gekko Brief
AI summaryFresenius Medical Care this week centers on a strategic shift in China, where the company is discontinuing production and sales of its 4008A hemodialysis system and exiting the peritoneal dialysis business in the country, a move expected to bring one-time costs of approximately €110 million in the third quarter of 2026. Alongside this, coverage notes that Q2 operating income rose 23% to €569 million, even as brokerages maintain a consensus "Reduce" recommendation with an average price target of $23.57.
FMS closed at $22.95, up 1.1%, sitting between its 50-day average of $23.48 and 200-day average of $23.05. The GekkoIndex reads 60.5, placing the stock in the Accumulation zone, though the index has declined 9.5 over the past five sessions. Price stands 40.9% below Gekko Fair Value of $38.84. Analyst coverage from 3 firms shows 0 buy, 2 hold and 1 sell ratings, with a consensus target of $25.35, implying 10.5% upside from current levels.
Over the next 20 trading days, the next earnings report is due 3 November 2026, before the open, 35 days out and outside a typical holding window. The prior report on 5 May 2026 saw EPS of $0.46 against an estimate of $0.53, with a reaction of -7.2%; the company has beaten estimates in 6 of the last 8 quarters, with an average absolute reaction of 5.9%. No insider, Congress, or unusual options activity appears in the respective windows. Seasonality from this calendar point shows a 5-year average 20-day return of -3.9%, positive in 2 of those years.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Fresenius Medical Care price vs fair value
Close $22.95200-day averageGekko Fair Value $38.84
Fresenius Medical Care quick facts
- Market cap
- $12.33B
- P/E ratio
- 12
- Forward P/E
- 8.6
- EPS, TTM
- $1.89
- Revenue, TTM
- $19.43B
- Profit margin
- 4.8%
- Dividend yield
- 3.84%
- Beta
- 0.83
- Volume
- 498,693 avg 670,463
- 1-year return
- −8.9%
- Typical daily move
- ±1.5%
- Typical 20-day move
- ±6.5%
- 50-day average
- $23.48
- 200-day average
- $23.05
- Next earnings
- Nov 3 before open
- Shares outstanding
- 532.2M
Fresenius Medical Care swing-trade checklist
Fresenius Medical Care scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendmixed
Averages disagree
Close $22.95 sits between the 50-day ($23.48) and 200-day ($23.05) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
60.5, Accumulation
Reading 60.5 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
40.9% below
Price is 40.9% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−3.9% on average
From this point in the calendar, the next 20 trading days averaged −3.9% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Fresenius Medical Care stock chart and price history
Fresenius Medical Care closed at $22.95 on Sep 28, 2026, −8.9% over the past year, inside a 52-week range of $20.02 to $27.64.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −1.4%
- 3 months
- +1.1%
- 6 months
- +4.0%
- 1 year
- −8.9%
The full FMS chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open FMS in Gekko
Follow Fresenius Medical Care through every session
Put FMS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track FMS in GekkoFree for 7 days. No credit card required.
About Fresenius Medical Care
Fresenius Medical Care works in kidney care, running clinics where people receive dialysis treatment along with related lab and diagnostic work. For patients who dialyze at home, it supplies the machines, trains them on use, and stays involved through medical oversight and by arranging delivery of supplies. In the United States it also partners with hospitals to treat inpatients dealing with acute kidney failure or end-stage renal disease.
On the product side, the company designs and builds dialysis equipment such as polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, solution concentrates, bloodlines, and water treatment systems, alongside renal drugs. It also makes devices unrelated to dialysis, including tools for acute cardiopulmonary support and apheresis. A separate pharmaceutical arm sources and develops specialized medicines for kidney patients, which are shipped both to people's homes and to treatment centers. The company additionally offers vascular, cardiovascular, and endovascular care, runs ambulatory surgery centers for vascular work, and supplies physician staffing in nephrology and cardiology. Its buyers include hospitals, dialysis clinics, and specialty centers, served through in-house sales staff as well as outside distributors, dealers, and agents.
The company traces back to 1996 and is headquartered in Bad Homburg, Germany, with operations spanning Germany, North America, and dozens of other countries. Its shares trade under the ticker FMS.
- Sector
- Health services
- Website
- freseniusmedicalcare.com
Fresenius Medical Care GekkoIndex: the smart money zone
Fresenius Medical Care’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.5, in the Accumulation zone, down 9.5 points over five sessions.
60.5Accumulation
Down 9.5 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 41 | +0.9% | +3.4% | ||
| Accumulation (current zone) | 188 | +0.7% | +2.8% | ||
| Neutral | 363 | 0.0% | −0.1% | ||
| Distribution | 33 | −0.6% | −1.7% | ||
| Selling | 0 | Not available | |||
Average FMS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the FMS price, zone by zone.Track FMS in Gekko
Is Fresenius Medical Care stock overvalued? Gekko Fair Value
Fresenius Medical Care trades 40.9% below Gekko Fair Value of $38.84, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Fresenius Medical Care shares are worth, recalculated every trading day.
$38.84
Gekko Fair Value, Sep 29, 2026
40.9% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open FMS in Gekko
Fresenius Medical Care insider and Congress trading
No open-market insider purchases were filed for Fresenius Medical Care, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in FMS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for FMS, plotted on the chart in Gekko.Open FMS in Gekko
Fresenius Medical Care earnings: next date and track record
Fresenius Medical Care reports on Nov 3, 2026, before the open (35 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 3, 2026
Expected before the open, 35 days away
- EPS estimate
- $0.61
- Revenue estimate
- $5.70B
6 of 8reports beat the EPS estimate
±5.9%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 5, 2026 | $0.46 est $0.53 | $5.40B est $5.41B | −7.2% |
| Feb 24, 2026 | $0.83 est $0.65 | $5.97B est $5.67B | −7.9% |
| Nov 4, 2025 | $0.64 est $0.59 | $5.72B est $4.80B | −8.0% |
| Aug 5, 2025 | $0.52 est $0.50 | $5.64B est $4.98B | −5.7% |
| May 5, 2025 | $0.42 est $0.38 | $5.35B est $5.06B | +7.1% |
| Feb 25, 2025 | $0.46 est $0.40 | $5.27B est $4.66B | +1.1% |
| Nov 5, 2024 | $0.40 est $0.38 | $5.22B est $5.22B | +5.2% |
| Jul 30, 2024 | $0.24 est $0.34 | $5.13B est $5.30B | −5.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Fresenius Medical Care stock forecast and analyst price targets
Analysts’ average 12-month price target for Fresenius Medical Care is $25.35, +10.5% from the last close, from 3 firms rating the stock in the last 90 days.
$25.35consensus 12-month target, +10.5% from the last close
Now $22.95Avg $25.35
Low $19.90High $25.80
Each firm’s latest rating in the last 90 days: 3 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 26 | Truist Financial | $25 | +8.9% |
| Aug 6 | Bernstein | $25.80 | +12.4% |
| Aug 5 | Truist Financial | $25 | +8.9% |
| Aug 4 | Truist Financial | — | — |
| Jul 28 | Exane BNP Paribas | $19.90 | −13.3% |
+2.8%average 20-day move after past Accumulation readings
−3.9%average move over the next 20 trading days in the last 5 years
±1.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Fresenius Medical Care seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Fresenius Medical Care averaged −3.9% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.5% | 1 of 5 |
| Next 10 trading days | −5.3% | 1 of 5 |
| Next 15 trading days | −3.5% | 2 of 5 |
| Next 20 trading days | −3.9% | 2 of 5 |
| Next 30 trading days | −5.3% | 1 of 5 |
For scale, FMS’s typical 20-trading-day move in either direction is about 6.5%.
Fresenius Medical Care market cap and key statistics
Fresenius Medical Care’s market cap is $12.33B, with a P/E ratio of 12 and revenue of $19.43B over the last twelve months.
Valuation
- Market cap
- $12.33B
- P/E ratio
- 12
- Forward P/E
- 8.6
- EPS, TTM
- $1.89
- Gekko Fair Value
- $38.84
Trading
- Volume
- 498,693
- Avg volume, 20 days
- 670,463
- 52-week high
- $27.64
- 52-week low
- $20.02
- Shares outstanding
- 532.2M
Financials
- Revenue, TTM
- $19.43B
- Profit margin
- 4.8%
- Return on equity
- 8.5%
- Quarterly earnings growth, YoY
- +5.5%
Risk and income
- Beta
- 0.83
- Typical daily move
- ±1.5%
- Typical 20-day move
- ±6.5%
- Dividend yield
- 3.84%
Fresenius Medical Care stock news this week
Coverage of Fresenius Medical Care this week reads neutral: 0 positive, 4 neutral and 1 negative headlines.
- Fresenius Medical Care stock at EUR 39.80 on September 25, 2026AD HOC NEWS, Sep 28
- Strategic shift in China costs Fresenius Medical Care €110mmarketscreener.com, Sep 25
- Fresenius Medical Care stock trades at USD 22.54 below yearly highAD HOC NEWS, Sep 25
- Fresenius Medical Care Plans to Exit China Peritoneal Dialysis BusinessYahoo Finance, Sep 25
- Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to BrokeragesMarketBeat, Sep 25
- Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market LeadershipPRNewsWire, Sep 25
Fresenius Medical Care stock FAQ
What is Fresenius Medical Care’s market cap?
Fresenius Medical Care’s market cap is $12.33B at the Sep 28, 2026 close of $22.95, with 532.2M shares outstanding. The shares trade on a P/E ratio of 12.
What is the Fresenius Medical Care stock forecast?
The consensus analyst 12-month price target for Fresenius Medical Care is $25.35, +10.5% from the last close. Of the 3 firms that rated the stock in the last 90 days, 0 rate it a buy, 2 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Fresenius Medical Care stock overvalued or undervalued?
On Gekko’s estimate Fresenius Medical Care is undervalued: the Sep 28, 2026 close of $22.95 is 40.9% below Gekko Fair Value of $38.84. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Fresenius Medical Care report earnings next?
Fresenius Medical Care is expected to report on Nov 3, 2026, before the market opens (35 days away). Analysts expect earnings of $0.61 per share on revenue of $5.70B. Fresenius Medical Care beat the earnings estimate in 6 of its last 8 reports, moving 5.9% on average across the report.
What is Fresenius Medical Care’s 52-week high and low?
Fresenius Medical Care’s 52-week high is $27.64 and its 52-week low is $20.02; it closed at $22.95 on Sep 28, 2026, −8.9% over the past year. Over the last five years the shares peaked at $36.08 on Oct 21, 2021.
Is Fresenius Medical Care stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Fresenius Medical Care the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.